Developer of cancer immunotherapy designed for the treatment of solid tumors. The company has developed cancer vaccines through its proprietary technology of targeted conjugate vaccines and has identified specific targets in the tumor vasculature, which directly targets and causes the destruction of endothelial cells in the tumor, enabling physicians to treat cancer effectively by preventing tumor growth.